References
- Shackelford D A, Kaufman J F, Korman A J, Strominger J L. HLA-DR antigens: structure, separation of subpopulations, gene cloning and function. Immun Rev 1982; 66: 133–187
- Schwartz R H. Immune response (Ir) genes of the murine major histocompatibility complex. Adv Immunol 1986; 38: 31–201
- Guillet J, Lai M, Briner J, Smith J, Gefter M. Interaction of peptide antigens and class II major histocompatibility complex antigens. Nature 1986; 324: 260–263
- Bjorkman P, Saper M, Samraoui B, Bennett W, Strominger J, Wiley D. The foreign antigen binding site and T cell recognition regions of class I histocompability antigens. Nature 1987; 329: 512–519
- Pellegrino M A, Russo C, Allison J. HLA antigens in serum. Methods Enzxmol 1984; 108: 614–624
- Kamada N, Brons G, Davies H S. Fully allogeneic liver grafting in rats induces a state of systemic nonreactivity to donor transplantation antigens. Transplantation 1980; 29: 429–431
- Spencer S C, Fabre J W. Identification in rat liver and serum of water-soluble class I MHC molecules possibly homologous to the murine Q10 gene product. J Exp Med 1987; 165: 1595–1608
- Singh P B, Brown R E, Roser B. MHC antigens in urine as olfactory recognition cues. Nature 1987; 327: 161–164
- Shackelford D A, Lampson L A, Strominger J L. Analysis of HLA-DR antigens by using monoclonal antibodies: recognition of conformation differences in biosynthetic intermediates. J Immunol 1981; 127: 1403–1410
- Finn O J, Levy R. Multiple HLA-DR antigens: Detection with monoclonal antibodies and translation in vitro. Proc Natl Acad Sci USA 1982; 79: 2658–2662
- Goronzy J, Weyand C M, Fathman C G. Cloning of human alloreactive T cells. Methods Enzymol 1987; 150: 333–341
- Weyand C M, Goronzy J J. Mapping of allospecific T-cell recognition sites encoded by the HLA-DR4 β1-chain. Human Immunology 1989; 24: 133–143
- Weyand C M, Goronzy J J. Disease-associated HLA determinants in patients with seropositive rheumatoid arthritis: functional role in antigen-specific and allogeneic T cell recognition. J Clin Invest 1990; 85: 1051–1057
- Thiele D L, Lipsky P E. The immunosuppressive activity of L-Leucyl-L-Leucine methyl ester: selective ablation of cytotoxic lymphocytes and monocytes. J Immunol 1986; 136: 1038–1048
- Stevenson F K, George A JT, Walters M T, Hamblin T J. Analysis of soluble HLA class II antigenic material in patients with immunological diseases using monoclonal antibodies. J Immunol Methods 1986; 86: 198–190
- Krangel M S. Secretion of HLA-A and-B antigens via an alternative RNA splicing pathway. J Exp Med 1986; 163: 1173–1190
- Emerson S G, Cone R E. I-Ak and H-2Kk antigens are shed as supramolecular particles in association with membrane lipids. J Immunol 1981; 127: 482–486
- Kao K. J, Scornik J C, Riley W J, McQueen C F. Association between HLA phenotype and HLA concentration in plasma or platelets. Human Immunol 1988; 21: 115–124
- Herlyn M, Lange B, Bennicelli J, Blaszczyk M, Guerry D, IV, Koprowski H. Increased levels of circulating HLA-DR antigen in sera of patients with acute lymphoblastoid leukemia. Leuk Res 1984; 8: 323–324
- Elliott T J, Eisen H N. Allorecognition of purified major histocompatibility complex glycoproteins by cytotoxic T lymphocytes. Proc Natl Acad Sci USA 1988; 85: 2728–2732
- Parham P, Clayberger C, Zom S L, Ludwig D S, Schoolnik A K, Krensky A M. Inhibition of alloreactive cytotoxic T lymphocytes by peptides from the a2 domain of HLA-A2. Nature 1987; 325: 625–628
- McCluskey J, Boyd L F, Highet P F, Inman J, Margulies D H. T cell activation by purified, soluble class I MHC molecules. J Immunol 1988; 141: 1451–1455